4//SEC Filing
Daniels Kevin 4
Accession 0001209191-23-011095
CIK 0001000229other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 3:15 PM ET
Size
6.0 KB
Accession
0001209191-23-011095
Insider Transaction Report
Form 4
Daniels Kevin
CAO & Treasurer
Transactions
- Award
Performance Shares
2023-02-16+12,240→ 12,240 totalExercise: $0.00→ Common Shares (12,240 underlying)
Footnotes (1)
- [F1]Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2023 and ends on December 31, 2025 (the "Performance Period"). At the end of the Performance Period, 50% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 100% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 50% up to 100% of the award).
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001740507
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 3:15 PM ET
- Size
- 6.0 KB